Tirzepatide is a next-generation, dual-action receptor agonist that targets both GLP-1 and GIP pathways. This powerful combination has shown significant promise in research focused on weight loss and metabolic health. Designed exclusively for non-clinical investigation, Tirzepatide provides researchers with a highly effective tool for exploring innovative metabolic therapies.
Now available in 10mg, 20mg, and 30mg formats, it supports a wide range of dosing protocols and research applications.
⸻
🔬 Key Benefits
• For Research Purposes Only – Not for human or clinical use
• Dual Mechanism of Action – Activates GLP-1 and GIP receptors for improved metabolic outcomes
• Flexible Dosing Options – Available in 10mg, 20mg, and 30mg vials
• Ideal for Advanced Studies – Supports research in obesity, insulin resistance, and metabolic disorders
• Free Injection Pen Included – Convenient dosing with every purchase
⸻
🧪 Product Details
• Form: Lyophilized peptide powder
• Storage: Keep in a cool, dry place. After reconstitution, store at 2–8°C
• Packaging: Each vial is securely sealed and includes a free injection pen
⸻
🛒 Now Available
Order Tirzepatide in your preferred strength—10mg, 20mg, or 30mg—and receive a free injection pen with each vial.
